Within the TME, M2-like TAMs promote cancer cell proliferation through the activation of the MMP9/HB-EGF pathway and epidermal growth factor (EGF) production, leading to the stimulation of VEGF signaling that supports tumor metastasis [36] (Figure 1). Here, MMP9 is linked to neoplasm.